JPRN-UMIN000053150招募中Unknown
Evaluation of the efficiency and safety of imeglimin on insulin secretion ability and insulin sensitivity in the treatment of type 2 diabetes mellitus - Evaluation of the efficacy and safety of imeglimin on insulin secretion ability and insulin sensitivity
Department of Diabetes and Metabolism,Tohto Clinic0 个研究点目标入组 30 人开始时间: 2023年12月25日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) eGFR<30 2) Pregnancy or breastfeeding
研究者
相似试验
招募中
4 期
Comparison of Effectiveness and Safety of Imeglimin and Metformin monotherapy in type 2 Diabetes: A StudyCTRI/2023/08/056584Other Self
已完成
不适用
The estimation for the safety and efficacy of ILM blue and membrane bleu dual for retina macular diseaseJPRN-UMIN000032712niversity of Fukui200
招募中
3 期
Investigating the effect of empagliflozin in heart failure in HIV patientsIRCT20130719014054N2Tehran University of Medical Sciences128
已完成
不适用
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944NL-OMON43676Vrije Universiteit Medisch Centrum33
尚未招募
4 期
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersDementiaRPCEC00000410Center of Molecular Immunology (CIM)1,456